Literature DB >> 20121714

Extracellular cAMP inhibits P2X receptors in rat sensory neurones through G protein-mediated mechanism.

M V Mamenko1, I V Chizhmakov, T M Volkova, A Verkhratsky, O A Krishtal.   

Abstract

AIM: To identify the mechanisms of P2X(3) receptor inhibition by extracellular cyclic adenosine monophosphate (cAMP) in rat dorsal root ganglion (DRG) neurones.
METHODS: Whole-cell currents were measured in cultured DRG neurones using the combination of voltage and concentration clamp.
RESULTS: We have found that extracellular cAMP inhibits P2X(3)-mediated currents in a concentration- and use-dependent manner. The P2X(3) currents, activated by ATP applied every 4 min, were inhibited by 55% in the presence of 10 microm cAMP and by 81% in the presence of 30 microm cAMP. At 8 min interval between ATP applications the same concentration of cAMP did not alter the currents. Addition of 0.5 mm of guanosine 5'-O-(2-thiodiphosphate) to intracellular solution blocked the inhibitory action of cAMP. The inhibitory effects of cAMP were not mimicked by extracellular application of 30 mum adenosine.
CONCLUSIONS: In this paper, we demonstrate, for the first time, that extracellular application of cAMP to rat sensory neurones inhibits P2X(3) receptors via a G protein-coupled mechanism in a use-dependent manner, thus indicating the neuronal expression of specific plasmalemmal cAMP receptor.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20121714     DOI: 10.1111/j.1748-1716.2010.02088.x

Source DB:  PubMed          Journal:  Acta Physiol (Oxf)        ISSN: 1748-1708            Impact factor:   6.311


  2 in total

1.  Identification of P2X₃ and P2X₇ purinergic receptors activated by ATP in rat lacrimal gland.

Authors:  Robin R Hodges; Joanna Vrouvlianis; Rachel Scott; Darlene A Dartt
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-05-17       Impact factor: 4.799

Review 2.  Desensitization properties of P2X3 receptors shaping pain signaling.

Authors:  Rashid Giniatullin; Andrea Nistri
Journal:  Front Cell Neurosci       Date:  2013-12-06       Impact factor: 5.505

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.